Performance was driven by a 29% unit growth in Oncology diagnostics, which management noted has been accelerating throughout the fiscal year. The Data business outperformed expectations with 69% growth in the quarter, fueled by a proprietary data set of over 450 petabytes of connected multimodal data. Management attributes their competitive moat to the 'flywheel' of using diagnostic data to train AI models, then delivering those insights back to physicians through 5,500 hospital connections. The Ins ...